1. 117PImmunoscore feasibility study in routine postsurgical pathologic review for early-stage colon cancer (CC) cases risk-assessment. (25th November 2018) Authors: Belaloui, K; Malifarge, E; Bohm, J; Bossard, C; Dienstmann, R; Garcia, S; Geppert, C; Gogenur, I; Hartmann, A; Hatzibougias, D; Landolfi, S; Mishaeli, M; Paez, D; Patel, P; Rodriguez-Justo, M; Szafranska, J; van den Eynde, M; Zavadova, E; Turcan, S; Hermitte, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-400ANCHOR CRC: a phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BINI), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC). (2nd July 2019) Authors: Grothey, A; Yaeger, R; Paez, D; Tabernero, J; Taïeb, J; Yoshino, T; Groc, M; Vedovato, J; Chetaille, E; Van Cutsem, E Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗